EXPD vs FOLD · P/E 26, rev $10.60B vs rev $528.3M
Expeditors International of Washington, Inc. (EXPD) versus Amicus Therapeutics Inc (FOLD) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. FOLD currently screens at market cap $1.80B.
Not investment advice. Open the EXPD and FOLD stock pages for the full models.
Not investment advice.